HCC is one of the most common types of malignancies worldwide and the fourth-leading cause of cancer deaths. Thus, there is an urgent need to search for novel targeted therapies in HCC. 186 m6a-relate
Processed bulk RNA-seq, spatial transcriptomics and scRNA-seq dataset of NSCLC related to the article “Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-